What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.31%
Annual Rate
CNY 0.30Paid annual
Payout Ratio
45.5%Sustainable
Payback Period
69.5 yr
Last Ex-Dividend
Jun 2, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.47BCNY
965.45M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
34.39x
Updated Sep 22, 2026
Revenue (TTM)
1.15BCNY
171.88M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
15.81%
Updated Sep 22, 2026
Beta
0.7730x
vs all stocks
Updated Sep 22, 2026
52-Week Change
-17.28%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
6.47BCNY
965.45M · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
7.23BCNY
1.08B · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
34.39x
Updated Sep 22, 2026
Price to Sales (TTM)
5.52x
Updated Sep 22, 2026
Price to Book (MRQ)
6.14x
Updated Sep 22, 2026
Enterprise to Revenue
6.28x
Updated Sep 22, 2026
Enterprise to EBITDA
21.42x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 27.13×.Updated Sep 22, 2026
Gross Margin
19.84%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 27.13%.Updated Sep 22, 2026
Profit Margin
15.81%
Updated Sep 22, 2026
Operating Margin
15.10%
Updated Sep 22, 2026
Return on Assets (TTM)
6.42%
Updated Sep 22, 2026
Return on Equity (TTM)
16.26%
Updated Sep 22, 2026
Revenue (TTM)
1.15BCNY
171.88M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
4.19CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
17.20%
Updated Sep 22, 2026
Gross Profit (TTM)
312.31MCNY
46.64M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
266.63MCNY
39.82M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
181.96MCNY
27.17M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
76.20%
Updated Sep 22, 2026
Operating Cash Flow (TTM)
329.58MCNY
49.22M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-21.44MCNY
-3.20M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing Annual Dividend Rate
0.3000CNYUpdated Sep 22, 2026
Trailing Annual Dividend Yield
1.31%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
45.45%
Updated Sep 22, 2026
Minority Interest (Equity)
165.44MCNYFY2025 · Dec 31, 2025
Revenue
1.02BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
733.53MCNYFY2025 · Dec 31, 2025
Gross Profit
287.31MCNYFY2025 · Dec 31, 2025
Operating Income
223.68MCNY
33.40M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
198.36MCNYFY2025 · Dec 31, 2025
Income Tax Expense
38.40MCNYFY2025 · Dec 31, 2025
Net Income
159.95MCNYFY2025 · Dec 31, 2025
EBIT
212.77MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
350.35MCNYFY2025 · Dec 31, 2025
Research & Development
24.48MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
11.59MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
9.16MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
547.20KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
14.42MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.5600CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.5600CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
278.57MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
278.57MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
159.95MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-3.96MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
150.63MCNYFY2025 · Dec 31, 2025
Free Cash Flow
11.50MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
100.73MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
159.95MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
17.46MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
32.43MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-59.22MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-139.13MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-83.34MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-222.47MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
598.64MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-484.83MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-82.59MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-168.53MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-137.32MCNYFY2025 · Dec 31, 2025
Shares Outstanding
280.00MSharesUpdated Sep 22, 2026
Float Shares
75.56MSharesUpdated Sep 22, 2026
% Held by Insiders
73.12%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
0.22%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
107.25MCNY
16.02M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
0.3830CNYUpdated Sep 22, 2026
Total Debt (MRQ)
818.17MCNY
122.18M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.6809x
Updated Sep 22, 2026
Current Ratio (MRQ)
0.7480x
Updated Sep 22, 2026
Book Value per Share (MRQ)
3.70CNYUpdated Sep 22, 2026
Total Assets
2.30BCNY
342.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
487.42MCNYFY2025 · Dec 31, 2025
Total Liabilities
1.11BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.81BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
450.66MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
654.61MCNYFY2025 · Dec 31, 2025
Cash
100.73MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
100.73MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
2.81MCNYFY2025 · Dec 31, 2025
Accounts Receivable
140.45MCNYFY2025 · Dec 31, 2025
Inventory
141.57MCNYFY2025 · Dec 31, 2025
Accounts Payable
206.67MCNYFY2025 · Dec 31, 2025
Short-term Debt
275.60MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.61MCNYFY2025 · Dec 31, 2025
Long-term Debt
371.86MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
280.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
384.32MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.19BCNY
177.75M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.97CNYUpdated Sep 22, 2026
52-Week High
45.00CNYUpdated Sep 22, 2026
52-Week Change
-17.28%
vs all stocks
Updated Sep 22, 2026
Beta
0.7730x
vs all stocks
Updated Sep 22, 2026
50-Day MA
18.95CNYUpdated Sep 22, 2026
200-Day MA
23.04CNYUpdated Sep 22, 2026
Avg 10-Day Volume
24.81MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
11.12MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
0.6600CNYUpdated Sep 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.41: safe zoneNotable
Altman Z-Score: 4.41
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Companies that share the same coordination system — how they create, deliver, or capture value.